Table 2 Characteristics of high risk participants by SBEM and ST1RE
SBEM (n = 67) | ST1RE (n = 14) | p-value | |
|---|---|---|---|
Age (years) | 38.1 (± 10.7) | 50.3 (± 9.9) | 0.0002* |
Sex | 1.000 | ||
Male | 34.9 (23) | 30.8 (4) | |
Female | 65.1 (43) | 69.2 (9) | |
Diabetes duration (years) | 27.0 (19.0; 32.0) | 34.0 (31.0; 42.0) | 0.029* |
Age of T1DM onset (years) | 11.0 (4.0; 17.0) | 16.0 (10.0; 28.0) | 0.065** |
Early onset T1DM (1–10 years of age) | 44.8 (30) | 28.6 (4) | 0.375 |
Late onset T1DM (> 10 years of age) | 55.2 (37) | 71.4 (10) | |
BMI (kg/m2) | 23.4 (21.4; 28.0) | 21.5 (20.4; 23.2) | 0.055** |
HbA1c (%) | 8.6 (7.6; 10.0) | 9.4 (7.8; 10.8) | 0.209** |
SBP (mmHg) | 122.0 (110.0; 130.0) | 133.0 (128.0; 144.0) | 0.004** |
DBP (mmHg) | 80.0 (70.0; 80.0) | 80.0 (78.0; 82.0) | 0.226** |
LDL-cholesterol (mg/dl) | 90.0 (70.4; 113.4) | 91.1 (71.2; 112.0) | 0.925** |
eGFR (CKD-EPI) (ml/min/1.73 m2 | 99.0 (72.0; 114.0) | 69.5 (33.0; 79.0) | 0.0005** |
Serum creatinin (mg/dL) | 0.85 (0.74; 1.03) | 1.04 (0.92; 1.84) | 0.0035** |
Albumin-Creatinin Ratio (mg/g) | 0.004 | ||
Normal | 52.2 (35) | 7.1 (1) | |
Microalbuminúria | 23.9 (16) | 42.9 (6) | |
Macroalbuminúria | 23.9 (16) | 50.0 (7) | |
Microvascular complications (%) | 83.6 (56) | 100.0 (14) | 0.197 |
Nephropathy (%) | 55.2 (37) | 92.9 (13) | 0.013 |
Retinopathy (%) | 74.6 (50) | 92.9 (13) | 0.175 |
Neuropathy (%) | 13.4 (9) | 28.6 (4) | 0.224 |
Treatments | |||
Statins | 52.2 (35) | 71.4 (10) | 0.244 |
ACE inhibitor or ARB | 67.2 (45) | 78.6 (11) | 0.532 |
AAS | 7.5 (5) | 28.6 (4) | 0.044 |
Physical activity | 11.9 (8) | 14.3 (2) | 0.681 |
Smoking | 4.8 (3) | 7.7 (1) | 0.541 |